Deepinder Goyal has publicly defended Temple against criticism from doctors, according to NDTV and The Times of India. The dispute puts the relationship between entrepreneurial claims and professional scrutiny in focus, but the available leads do not resolve it. [9][10]

What the reporting establishes

India Today frames the controversy as a disagreement between startup founders and doctors. NDTV’s headline reports Goyal’s rejection of the suggestion that Temple is a scam. That establishes his position, not an independent finding about Temple. [6][9]

The supplied material does not explain Temple’s operation, identify the evidence behind its claims or set out the doctors’ objections in detail. It therefore cannot support a verdict about effectiveness, safety or wrongdoing.

A standard for credible innovation

Sanatan Daily’s assessment is that entrepreneurial ambition and expert scrutiny need not be opposing forces. Neither a founder’s confidence nor professional criticism should substitute for evidence that others can examine.

The useful next step is clarity: what is being claimed, what supports it and what remains uncertain. For India’s innovation culture, transparent evaluation offers a more durable foundation than a contest over who deserves automatic trust.